These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cholinergic symptoms with low serum cholinesterase from therapeutic cholinesterase inhibitor toxicity.
    Author: Leikin JB, Braund V, DesLauris C.
    Journal: Am J Emerg Med; 2014 Jul; 32(7):815.e3-4. PubMed ID: 24589024.
    Abstract:
    Although cholinesterase inhibitors have been frequently used in the treatment of Alzheimer disease, its effects on serum cholinesterase concentrations have been rarely described. We described significant depression of serum cholinesterase levels due to cholinesterase inhibitor toxicity from redundant use of donepezil and rivastigmine in a 78-year-old man. Recovery of serum cholinesterase level was noted upon drug discontinuation and cholinergic symptom resolution. Serum cholinesterase level can be used as a biomarker for central cholinesterase inhibitor toxicity.
    [Abstract] [Full Text] [Related] [New Search]